Prognostic prediction across a gradient of total tumor volume in patients with hepatocellular carcinoma undergoing locoregional therapy
about
Anti-α-enolase is a prognostic marker in postoperative lung cancer patientsPrognostic role of noninvasive liver reserve markers in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.Treatment algorithm based on the multivariate survival analyses in patients with advanced hepatocellular carcinoma treated with trans-arterial chemoembolizationMethodological assessment of HCC literatureMicrovascular invasion (MVI) is a poorer prognostic predictor for small hepatocellular carcinoma.Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1.Predictors of Outcome of Living Donor Liver Transplantation for Hepatocellular Carcinoma.Ascites in patients with hepatocellular carcinoma: prevalence, associated factors, prognostic impact, and staging strategy.Downregulation of betaine homocysteine methyltransferase (BHMT) in hepatocellular carcinoma associates with poor prognosis.Clinical implication of performance status in patients with hepatocellular carcinoma complicating with cirrhosis.Impact of tumor burden on prognostic prediction for patients with terminal stage hepatocellular carcinoma: A nomogram study.Nomogram of the Barcelona Clinic Liver Cancer system for individual prognostic prediction in hepatocellular carcinoma.Toll-like receptors 3, 4 and 9 in hepatocellular carcinoma: Relationship with clinicopathological characteristics and prognosis.Prognostic significance of alpha-fetoprotein status in the outcome of hepatocellular carcinoma after treatment of transarterial chemoembolization.
P2860
Q28601320-3638D253-F826-46BA-933C-27A318A33D71Q33865883-8FF04AE1-A140-413E-992F-09CEA760396FQ36272834-CD075680-F564-40BA-A5DC-5AC0A8C84980Q36963820-B4A858DD-568B-4BC1-961C-6FA64C40C55AQ37580894-D5DECFBE-DFFB-4C60-B57C-AC2E5E6CF4BBQ37641616-C0CC6A0B-5FAF-489A-8D9D-BAC880328CAAQ38615125-D091F8AF-CC9D-4F5D-B8C9-B8781DDDE0E0Q40707614-F459E5E2-188C-459F-ADA8-8DA6C1D4BBFDQ41107415-D7108E6B-5F5D-4D11-8BB9-286EA82F1143Q43176244-D729A3B9-AA0E-479F-AC7A-3247DBA2CB1EQ47111385-E1068E26-4B90-4268-8BA4-4E13696D8F12Q48061197-EDE7AE21-5D18-4317-A03F-A804A4780343Q51872814-36AE90B5-41FA-4329-96AE-453DC91B1D60Q53271003-8C230256-5F4B-4829-B4BD-34337AC03A8A
P2860
Prognostic prediction across a gradient of total tumor volume in patients with hepatocellular carcinoma undergoing locoregional therapy
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Prognostic prediction across a ...... ndergoing locoregional therapy
@ast
Prognostic prediction across a ...... ndergoing locoregional therapy
@en
Prognostic prediction across a ...... ndergoing locoregional therapy
@nl
type
label
Prognostic prediction across a ...... ndergoing locoregional therapy
@ast
Prognostic prediction across a ...... ndergoing locoregional therapy
@en
Prognostic prediction across a ...... ndergoing locoregional therapy
@nl
prefLabel
Prognostic prediction across a ...... ndergoing locoregional therapy
@ast
Prognostic prediction across a ...... ndergoing locoregional therapy
@en
Prognostic prediction across a ...... ndergoing locoregional therapy
@nl
P2093
P2860
P356
P1433
P1476
Prognostic prediction across a ...... ndergoing locoregional therapy
@en
P2093
Chia Y Hsu
Jen H Chiang
Rheun C Lee
Shou D Lee
Yi Y Chiou
P2860
P2888
P356
10.1186/1471-230X-10-146
P577
2010-12-31T00:00:00Z
P6179
1011927580